3 results

Photograph: iStock

Biopharmaceutical firm Amryt said it had a strong year in 2017 as revenue rose to almost €13 million. The company, which focuses on rare and orphan (...)

Photograph: iStock

Irish biopharmaceutical firm Amryt has signed a new distribution agreement, its fourth in recent months. The company, whcih focuses on rare diseases(...)

Amryt has reached a deal to sell a treatment for a cholesterol disorder that can lead to heart attacks in childhood.

Shares in Amryt, the Dublin-listed pharmaceutical company focused on developing treatments for rare or “orphan” diseases, surged as much as 18 per cen(...)